Ozempic leaves CPG items on the shelf
Some investors reacted negatively to The J.M. Smucker Co.’s acquisition of Hostess, doubting that the recent growth in indulgent snacking can continue. (Chart: Barchart.com Inc.)
Call it the Ozempic bear thesis. On recent CPG earnings calls, analysts have been asking about the diabetes medication’s impact with management teams. Some dismiss the risk while others, like PepsiCo, are redesigning products with healthier ingredients and/or smaller pack sizes...
https://www.freightwaves.com/news/health-issues-loom-over-cpg-industry